Albumin use is beneficial in cirrhotic patients

• Main Authors: Sanai Faisal, Marotta Paul
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2007-01-01
• Series: The Saudi Journal of Gastroenterology
• Subjects: Albumin; ascites; circulatory dysfunction; cirrhosis; hepatorenal syndrome; large volume paracentesis; spontaneous bacterial peritonitis
• Online Access: http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2007;volume=13;issue=4;spage=200;epage=203;aulast=Sanai

There are several indications for the use of albumin in patients with decompensated cirrhosis and its role has existed in clinical practice for many decades. While the drug enjoys immense popularity, it yet attracts intensive debate amongst clinicians and pharmacologists alike. Regardless of its pharmacological properties, its clinical use in cirrhotic patients has its fair share of proponents and opponents. At present, in the setting of cirrhosis this debate centers around the treatment of spontaneous bacterial peritonitis, in patients with ascites treated with large volume paracentesis, and in those with hepato-renal syndrome. With the evolving evidence it has become imperative to shed old dogmas and address this issue in the light of evidence-based medicine. This article gives a representative view of albumin use in the above conditions across both sides of the clinical divide.